|Min SIP Amount||Not Supported|
|NAV||₹12.47 (23 Jul 2021)|
|Fund Started||27 Mar 2018|
|Fund Size||₹235 Cr|
|HDFC Bank Ltd.||Financial||Equity||8.7%|
|ICICI Bank Ltd.||Financial||Equity||7.1%|
|Bharti Airtel Ltd.||Communication||Equity||6.1%|
|State Bank of India||Financial||Equity||5.3%|
|Rallis India Ltd.||Chemicals||Equity||4.3%|
|PI Industries Ltd.||Chemicals||Equity||4.2%|
|Chambal Fertilisers & Chemicals Ltd.||Chemicals||Equity||3.8%|
|Coromandel International Ltd.||Chemicals||Equity||3.6%|
|Bajaj Electricals Ltd.||Consumer Durable||Equity||3.5%|
UTI Long Term Advantage Fund Series VII Direct Growth is a Equity Mutual Fund Scheme launched by UTI Mutual Fund. This scheme was made available to investors on 27 Mar 2018. Lalit Nambiar is the Current Fund Manager of UTI Long Term Advantage Fund Series VII Direct Growth fund.The fund currently has an Asset Under Management(AUM) of ₹235 Cr and the Latest NAV as of 23 Jul 2021 is ₹12.47.
The UTI Long Term Advantage Fund Series VII Direct Growth is rated Very High risk.
The investment objective of the scheme is to provide medium to long term capital appreciation along with income tax benefit.